RisCView: June 2021
Monthly performance ranking of investment products.
Market Commentary: June 2021
Market Commentary: June 2021 Global Market Themes: Solid month for Developed Market (DM) equities as Covid-19 restrictions ease US stocks shine, supported by favourable economic data Widening gap between vaccine roll-out in DM and Emerging Markets (EM) takes its...China Market Commentary: June 2021
China Market Commentary: June 2021 Here are this month’s highlights: The MSCI China and MSCI China A Onshore indices were down 6.9% and 2.2%, respectively. On the macro front, the Chinese Yuan appreciated strongly in May to a three-year high against the US dollar....RisCView: May 2021
Monthly performance ranking of investment products.
Market Commentary: May 2021
Market Commentary: May 2021 Global Market Themes: Improved COVID-19 numbers boost global growth prospects US equities post solid performance, while UK and European stocks outperform Emerging markets outperform developed peers for the first time since January 2021...China Market Commentary: May 2021
China Market Commentary: May 2021 Here are this month’s highlights: In April, amid a global equity rebound, US markets reached record highs on the back of dovish signals from the Fed and optimism over economies reopening thanks to the COVID-19 vaccine rollout in the...RisCView: April 2021
Monthly performance ranking of investment products.
RisCura – SAVCA Private Equity Performance Report: South Africa Q3 2020
We are pleased to release the September 2020 edition of the RisCura – SAVCA South African Private Equity Performance Report.This report tracks the performance of a representative basket of South African private equity funds and is published quarterly. The...Market Commentary: April 2021
Market Commentary: April 2021 Global Market Themes: Global equity rally continues, as vaccine rollout gathers momentum Biden’s climate policy lauded as a step in the right direction Eurozone enters technical recession in first quarter of 2021 India’s surging...RisCView: March 2021
Monthly performance ranking of investment products.